Primary markets have been receiving healthy response from equity investors in 2016 as initial public offers from companies were subscribed up to 73.55 times in 2016 so far.
Primary markets have been receiving healthy response from equity investors in 2016 as initial public offers (IPO) from companies such as Thyrocare Technologies, Teamlease Services and Ujjivan Financial Services were subscribed 73.55 times, 66.25 times and 40.68 times in 2016 so far.
- Ujjivan Financial Services shares debut on bourses, lists 10% up at Rs 231.90 on NSE
- How cricketer Yuvraj Singh is helping Suditi Industries shares soar
Shares of these companies made strong debut on bourses on listing day. For instance shares of Thyrocare Technologies made opened over 45 per cent higher than its issue price.
On the robust response from investors, Chandan Taparia, analyst, Anand Rathi Securities said, “The subscription trend clearly indicates confidence among market participants.”
Below are the 5 IPOs which made stellar debut on BSE and NSE in the past one year
Thyrocare Technologies: Shares of diagnostics company Thyrocare Technologies made a blockbuster debut at the bourses on Monday, rising more than 49 per cent over the issue price of Rs 446. The stock listed at Rs 662, reflecting a huge premium of 48.43 per cent over the issue price on BSE.
Equitas Holdings: Equitas Holdings shares listed on April 21 at price of Rs 144 on BSE, up 30.91 per cent, against the issue price of Rs 110. On the National Stock Exchange (NSE), shares of the company listed at Rs 145.10, up 31.91 per cent, against the issue price.
Narayana Hrudayalaya: Narayana Hrudayalaya shares made a strong debut on bourses in January and got listed at Rs 291 with a premium of over 16 per cent over its issue price of Rs 250.
Dr Lal Path Labs: Dr Lal Pathlabs opened 30.36 per cent up from its issue price of Rs 550. Dr Lal’s IPO was a huge success as well with 33.41 times over-subscription. The price band was fixed at Rs 540-550 per share for the Rs 638 crore IPO.
Alkem Laboratories: Alkem Laboratories shares opened 31.42 per cent up from its issue price of Rs 1,050 on BSE. Alkem had raised about Rs 1,350 crore at an issue price of Rs 1,050 per share from its IPO, which was over-subscribed 44.29 times.